MDA Breakout Stocks Week 39 - September 2022: Short-Term Picks To Give You An EdgeSeeking Alpha • 09/26/22
Merck Stock Surges After Winning Patent Battle Vs. Viatris Over Two Key DrugsInvestors Business Daily • 09/22/22
LYNPARZA® (olaparib) Approved in China as First-Line Maintenance Treatment With Bevacizumab for Homologous Recombination Deficient (HRD)-Positive Advanced Ovarian CancerBusiness Wire • 09/22/22
U.S. District Court Rules In Favor of Merck in Sitagliptin Phosphate Patent LawsuitBusiness Wire • 09/22/22
7 ‘Strong Buy' Defensive Dividend Stocks to Grab Now as Markets May Return to June Lows24/7 Wall Street • 09/20/22
Merck launches new Phase 3 trial of once-daily HIV treatment, to discontinue trial of once-monthly doseMarket Watch • 09/20/22
Merck to Initiate New Phase 3 Clinical Program with Lower Dose of Daily Oral Islatravir in Combination with Doravirine for Treatment of People with HIV-1 InfectionBusiness Wire • 09/20/22
Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Infants and ChildrenBusiness Wire • 09/16/22
Goldman Sachs Says Beware of Dangerous Fall Market Volatility: 7 Safe Conviction List Dividend Stocks to Buy Now24/7 Wall Street • 09/14/22